Investigating the effects of thymol and cinnamaldehyde in T-2 toxin-treated hepatic cell cultures of chicken origin Authors: Júlia Vörösházi, Máté Mackei, Rege A. Márton, Evelin Kámán-Tóth, Ágnes Kemény, Zsuzsanna Neogrády, Gábor Mátis Published: 2026 ABSTRACT Trichothecenes are among the most significant mycotoxins, causing serious agricultural problems worldwide. One representative of these is T-2 toxin, which is often found in poultry feed. Due to its harmful effects, it is important to investigate substances that can counteract it. Such compounds include thymol and cinnamaldehyde, whose anti-inflammatory and antioxidant activities are well-documented.In this study, the effects of 24 h exposure to T-2 toxin (100 nM), thymol, and cinnamaldehyde (10 and 100 μg/mL in both cases) and their combinations with the toxin were examined in chicken-derived 3D liver cell cultures. Cellular viability was assessed by measuring the lactate dehydrogenase (LDH) activity. Inflammatory parameters were monitored by Luminex method, while the levels of oxidative and autophagy markers were determined by chicken-specific ELISA tests. Our results indicated that neither compound significantly affected cellular viability. T-2 toxin decreased interferon-γ (IFN-γ) and “Regulated on Activation, Normal T cell Expressed and Secreted” (RANTES), while increased macrophage colony-stimulating factor (M-CSF). Sole treatment of cinnamaldehyde reduced interleukin (IL)-10, IFN-γ, and RANTES, whereas thymol elevated IL-6 but lowered M-CSF and RANTES. In combination treatments, cinnamaldehyde further decreased IFN-γ, M-CSF, and RANTES, while thymol increased IL-6, IL-10, IFN-γ, and M-CSF relative to the T-2 toxin-treated cells. Thymol reduced nuclear factor (erythroid-derived 2)-like 2 (NRF-2), whereas cinnamaldehyde increased NRF-2 during combination treatment compared to the T-2 toxin-treated cells. Malondialdehyde (MDA) levels were lowered by cinnamaldehyde. Both compounds increased microtubule-associated protein 1 light chain 3 beta (LC3B) in combination treatments; however, cinnamaldehyde reduced P62 compared to the T-2 toxin-treated group.These results show that T-2 toxin exerted its negative effects by influencing inflammatory processes, but it was not cytotoxic. Thymol and cinnamaldehyde exhibited anti-inflammatory and, in some cases, even pro-inflammatory activity. In addition, both protective substances helped to initiate autophagy mechanisms in cells and influenced redox-related markers; cinnamaldehyde decreased MDA levels, while thymol modulated NRF-2 expression. Introduction Mycotoxins are secondary metabolites produced by fungi that cause significant agricultural problems worldwide (Ghareeb et al., 2015; Li et al., 2011). To date, more than 900 mycotoxins have been identified, posing significant threats to both animal and human health (Taroncher et al., 2025). Exposure to mycotoxins is inevitable, as they are natural contaminants of agricultural products and are difficult to eliminate due to their chemical stability and resistance to conventional food processing techniques (Seyed Toutounchi et al., 2019; Taroncher et al., 2025). Mycotoxins of particular importance are trichothecenes produced by various Fusarium species that infect various crops (Li et al., 2011). These toxins form a chemically diverse group, but only a few are relevant to animal and human health, including T-2 toxin, deoxynivalenol (DON), nivalenol, and fusarenone-X (Meneely et al., 2023). These toxins are structurally tetracyclic sesquiterpene alcohols or esters containing a 12,13-epoxide group, which plays an essential role in toxicity (Desjardins et al., 1993; Meneely et al., 2023). They can be divided into four groups (Type A, B, C, and D) based on the substitution pattern (McCormick et al., 2011). T-2 toxin is the most common and cytotoxic member of the Type A trichothecenes and is predominantly found in maize, oats, barley, and wheat (Krska et al., 2001; McCormick et al., 2011; Meneely et al., 2023; Taroncher et al., 2025). Since poultry species often consume cereals contaminated by the toxin, they are susceptible to mycotoxicosis caused by T-2 toxin (Kiš et al., 2021). Avians are generally less sensitive to the toxins than mammals, but longer-term exposure can still cause serious problems (Awad et al., 2008; Vörösházi et al., 2024). The main effects of T-2 toxin in poultry are reduced feed intake and body size, impaired immune system, gastrointestinal, neurological, and reproductive disorders, which are mainly exerted through inhibition of protein synthesis (Awad et al., 2012; Osselaere et al., 2013). In addition, it can induce oxidative stress in cells, which may be associated with increased lipid peroxidation, alterations in inflammatory signaling pathways, and apoptosis (Li et al., 2011; Vörösházi et al., 2024). In addition to apoptosis, it is important to highlight autophagy, a rescue pathway in cells. These processes are often interconnected, since when autophagy is unable to protect cells from external stressors, apoptosis is induced (Glick et al., 2010; Wang et al., 2018). It is likely that trichotechenes influence these processes in a dose-dependent manner, since at lower concentrations, T-2 toxin activates both autophagy and apoptosis, whereas at high doses, pro-apoptotic effects predominate (Wu et al., 2019). The effect of T-2 toxin on the immune system is dual; it can activate or suppress it depending on the dose and exposure time (Taroncher et al., 2025; Wu et al., 2020). Its stimulating effect on cytokine production has been described in several cell types, suggesting the initiation of inflammatory processes (Kruber et al., 2011; Wu et al., 2020). This toxin-induced inflammation is associated with oxidative stress, ROS production, and lipid peroxidation (Taroncher et al., 2025; Wu et al., 2020). Some signaling pathways that play a significant role in maintaining the cellular oxidative homeostasis, such as the nuclear factor (erythroid-derived 2)-like 2 (NRF-2) pathway also has a role in limiting inflammation (Dai et al., 2019; Taroncher et al., 2025). Given the harmful effects of these toxins, it is crucial to investigate compounds that may help prevent or mitigate their impact. Essential oils (EOs) might be suitable candidates for protecting against various toxic agents, as they are natural, less harmful, free from different residues, and they are also believed to promote growth in poultry (Zhai et al., 2018; Zhang et al., 2014). EOs are mixtures of volatile substances produced by living organisms and isolated from the whole plant or parts of the plant by purely physical methods, such as pressing or distillation (Zhai et al., 2018). These oils are often rich in aldehydes, phenols, alcohols, terpenes and ether oxides (Hammer and Carson, 2011; Saad et al., 2013). Their anti-inflammatory, antibacterial, antioxidant, and immunoregulatory effects have already been described, as well as their potential to enhance disease resistance, production performance, and intestinal health (Li et al., 2023). In addition, their antifungal and mycotoxin inhibitory effects are widely reported (Qi et al., 2023). Since they are composed of several components, their effects should be due to these and their interactions. However, two or three main constituents could account for up to 85% of the total mixture and thus for the primary effects of the essential oil (Miguel, 2010; Zhai et al., 2018). One such phenolic compound is thymol (2-isopropyl-5-methylphenol), which is known to have health-promoting, biocide and antitoxin effects (de Oliveira et al., 2014; Marchese et al., 2016). Thymol, together with carvacrol, is the main oil constituent of thyme (Thymus vulgaris), as well as other members of the Lamiaceae family (de Oliveira et al., 2014; Majdi et al., 2017; Marchese et al., 2016). Thymol has well-known anti-inflammatory and antioxidant effects and positively influences broiler growth performance (Li et al., 2023). Trans-cinnamaldehyde (trans-3-phenyl-2-propenal) is another naturally occurring plant-derived compound that is a potential alternative to antibiotics (Han et al., 2016; Shen et al., 2020a). More than 80% of the essential oil of cinnamon bark essential oil is cinnamaldehyde, whose anti-inflammatory, antioxidant, antibacterial, and pro-apoptotic effects have already been described (Roth-Walter et al., 2014). It has been shown to strengthen the immune response in broiler chickens, enhanced growth performance, and improved the absorption of nutrients from the intestine (Liu et al., 2024; Yang et al., 2021). In this study, the effects of T-2 toxin, thymol and cinnamaldehyde were investigated on chicken-derived 3D hepatic cell cultures. The liver plays a significant role in metabolic processes, including the biotransformation of toxic substances. It is the primary organ for the metabolism and detoxification of T-2 toxin (Taroncher et al., 2025; Yang et al., 2017). For this reason, it is worth investigating the mechanism of action of this toxin and various protective substances on primary liver cell cultures. These cultures were created using magnetic 3D bioprinting. During the development of these cultures, the cells are treated with magnetic nanoparticles consisting of gold, poly-L-lysine, and iron oxide. These particles bind to the cell membrane via poly-L-lysine and render them responsive to a magnetic field, leading to their arrangement into 3D structures in a magnetic field (Tseng and Souza, 2022; Vékony et al., 2022). These nanoparticles are biocompatible and do not interfere with cell growth and physiology (Desai et al., 2017). These cell cultures can reflect the in vivo conditions better, thus providing a more accurate picture of various cellular mechanisms of action (Souza et al., 2018; van Zijl and Mikulits, 2010). Our aim was to investigate the protective effects of thymol and cinnamaldehyde against T-2 toxin, as well as to provide insight into the molecular mechanisms of these compounds. Materials and methods Animal welfare statement All animal procedures were conducted in compliance with international and national regulations, as well as institutional rules. The Government Office of Zala County, Food Chain Safety, Plant Protection, and Soil Conservation Directorate, Budapest, Hungary, authorized the research (license number: ZAI/040/00522–7/2020). The study was carried out in accordance with the ARRIVE guidelines 2.0 (https://arriveguidelines.org/). The animals were fed and grown according to the standards of the Ross Technology (Aviagen, 2018). Isolation of the cells All reagents used in this study were purchased from Merck KGaA (Darmstadt, Germany), unless otherwise specified. The liver cells were isolated from 3-week-old male Ross 308 broiler chickens (obtained from Gallus Poultry Farming and Hatching Ltd, Devecser, Hungary) according to the protocol previously described by our research group (Mackei et al., 2020; Vörösházi et al., 2025, 2024). The liver was perfused in three steps through the gastropancreaticoduodenal vein. Firstly, the liver was perfused with 150 mL of 0.5 nM ethylene glycol tetraacetic acid (EGTA)-containing Hanks' Balanced Salt Solution (HBSS), followed by 150 mL of EGTA-free HBSS. Lastly, 130 mL of 1 mg/mL type IV collagenase (Nordmark, Uetersen, Germany) containing HBSS (supplemented with 7 mM MgCl2 and CaCl2) was washed through the organ to disrupt the extracellular matrix and release the cells. After the isolation, hepatocytes and non-parenchymal (NP) cells were separated by differential centrifugation. William's Medium E supplemented with 0.22% NaHCO3, 50 mg/L gentamycin, 2 mM glutamine, 4 µg/L dexamethasone, 20 IU/L insulin, and 5% foetal bovine serum (FBS) was used as culture medium. Bürker chamber and trypan blue exclusion staining were used to determine cell viability and total cell count. The number of viable cells was more than 90% for both cell types, making them suitable for seeding. After mixing the hepatocyte and NP-cell suspensions, the cell ratio was set to 6:1, and the concentration to 5 × 105 cells/mL. Both fractions were characterized in a preliminary study, and the NP cell fraction consisted largely of primary macrophages (Mackei et al., 2020). Preparation of 3D cell cultures 3D cell cultures were prepared by magnetic 3D bioprinting, for which the required equipment was purchased from Greiner Bio-One Hungary Ltd (Mosonmagyaróvár, Hungary). Cell culturing was carried out according to the manufacturer's protocol, as previously established by our research group (Vörösházi et al., 2025, 2024). First, magnetic nanoparticles (NanoShuttleTM-PL) were added to the hepatocyte-NP cell suspension in 1:10 ratio, then the cells were seeded onto 96-well cell-repellent plates and incubated for 1 h at 37°C, during which time the particles bound to the membranes and magnetized the cells. The plate was then placed on a magnetic Spheroid Drive, and the cultures were incubated for 48 h at 37°C in a humid atmosphere with 5% CO2. During this time, the cells were arranged into 3D structures. A so-called Holding Drive was used during medium exchange and the application of the treatment solutions to preserve the integrity of the formed spheroids. Treatment of the cells After 48 h, the 3D structures were formed. Thereafter, cells were treated with 100 nM T-2 toxin and two concentrations (10 and 100 μg/mL) of cinnamaldehyde or thymol. The treatment groups are summarized in Table 1. Cultures were treated for 24 h, then samples were collected from the cell culture media. Afterwards, cells were lysed in 40 μL phosphate buffer solution (PBS) by intermittent sonication (1/second) using a Bandelin Sonopuls HD 2200 homogenizer (Bandelin Electronic GmbH & Co. KG, Berlin, Germany). The samples were then stored at -80°C until further use.Table 1The setup of the treatment groups. Control: untreated cells. The abbreviations are as follows: T-2: T-2 toxin; CA: cinnamaldehyde; THY: thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions.GroupT-2 toxinCinnamaldehydeThymolControl---CA10-10 μg/mL-CA100-100 μg/mL-THY10--10 μg/mLTHY100--100 μg/mLT-2100 nM--T-2+CA10100 nM10 μg/mL-T-2+CA100100 nM100 μg/mL-T-2+THY10100 nM-10 μg/mLT-2+THY100100 nM-100 μg/mL Table 1The setup of the treatment groups. Control: untreated cells. The abbreviations are as follows: T-2: T-2 toxin; CA: cinnamaldehyde; THY: thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions.GroupT-2 toxinCinnamaldehydeThymolControl---CA10-10 μg/mL-CA100-100 μg/mL-THY10--10 μg/mLTHY100--100 μg/mLT-2100 nM--T-2+CA10100 nM10 μg/mL-T-2+CA100100 nM100 μg/mL-T-2+THY10100 nM-10 μg/mLT-2+THY100100 nM-100 μg/mL The setup of the treatment groups. Control: untreated cells. The abbreviations are as follows: T-2: T-2 toxin; CA: cinnamaldehyde; THY: thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Assessing the cellular viability Cell viability was determined by measuring the activity of the extracellular lactate dehydrogenase (LDH) enzyme using the LDH Activity Assay Kit. LDH is released from the cells when cell membranes are damaged, from which the amount of viable cells can be estimated. The higher the LDH activity in a sample, the lower the number of viable cells. The assay was performed according to the manufacturer's protocol. First, 50 µL of Master Reaction Mix (48 µL LDH Assay Buffer, 2 µL LDH Substrate Mix) was added to 50 µL of sample, then the absorbance was read at 450 nm with a Multiskan GO 3.2 reader (Thermo Fisher Scientific, Waltham, MA, USA) every 5 min until the absorbance of the sample with the highest LDH activity exceeded the absorbance of the most concentrated standard. Afterwards, LDH activity was calculated using the equation in the manufacturer’s protocol. Monitoring cellular inflammation To monitor the immune response induced by the different treatments, interleukin (IL) -6, IL-10, interferon-γ (IFN-γ), macrophage colony-stimulating factor (M-CSF), and “Regulated on Activation, Normal T cell Expressed and Secreted” (RANTES) were measured from the cell culture media by Luminex xMAP Technology, using Milliplex Chicken Cytokine/Chemokine Panel 1 -Immunology Multiplex Assay. The steps were performed according to the manufacturer's protocol. First, 25 μL of Assay Buffer was measured into the 96-well microplate provided with the kit. Subsequently, 25 μL of sample were added in duplicates. Then, 25 μL of five sets of coloured capture antibody-coated beads were applied to each well, followed by an overnight incubation at 2-8°C on a plate shaker. Afterwards, 25 μL biotinylated detection antibody and 25 μL streptavidin-phycoerythrin solutions were applied. Following this, 150 μL drive fluid was added, and the beads were resuspended on a plate shaker for 5 min. Finally, the reading was performed with Luminex MAGPIX® instrument (Luminex Corporation, Austin, TX, USA), and data were assembled by the Luminex xPonent 4.2 program. According to the median fluorescence intensity of the beads, standard curves were generated by Belysa Immunoassay Curve Fitting software for all analytes. Monitoring oxidative stress To investigate oxidative stress in cells, the amount of NRF-2 (SKU: MBS8807992) was assessed in cell lysate samples, and the concentration of MDA (SKU: MBS260816), was determined in cell culture medium samples using chicken-specific ELISA kits (MyBioSource, San Diego, CA, USA). The measurements were performed following the manufacturer's protocol. Absorbance values were obtained with a Multiskan GO 3.2 reader at 450 nm. Monitoring Autophagy To assess autophagy in cells, two autophagy markers, microtubule-associated protein 1 light chain 3 beta (LC3B) (SKU: MBS7264972) and P62 (protein with molecular weight of 62 kDa) (SKU: MBS025077), were quantified using chicken-specific ELISA kits (MyBioSource, San Diego, CA, USA) from cell lysates, following the manufacturer's protocol. Absorbance values were then determined with a Multiskan GO 3.2 reader at 450 nm. Total protein concentration Total protein concentrations were determined by PierceTM Bicinchoninic Acid (BCA) Protein Assay (Thermo Fisher Scientific, Waltham, MA, USA) using bovine serum albumin (BSA) as standard. According to the manufacturer's instructions, 25 μL of lysate, followed by 200 μL of color reagent, was added to a 96-well microplate. This was then incubated at 37°C for 30 min, protected from light. Absorbance values were read with a Multiskan GO 3.2 reader at 562 nm. Total protein values were used to standardize the results obtained from the cellular measurement. Statistical analysis The statistical analysis was performed using R Statistical Software (R Core Team 2023). The treatment groups consisted of 12 replicates (n=12/group). Results were corrected with data obtained from the BCA Protein Assay. During the analysis, groups treated with T-2 toxin, cinnamaldehyde or thymol alone were compared to the control group, while groups receiving combination treatments were compared to the T-2 toxin-treated group. Shapiro–Wilk and Levene’s tests were performed to verify the normal distribution and homogeneity of variance. One-way analysis of variance (ANOVA) was used to compare differences between groups, and Tukey’s post hoc test was used for pairwise comparisons. Results were expressed as mean ± standard error of the mean (SEM). Differences were considered significant at p < 0.05. Relative absorbances were calculated by considering the mean value of the Control group as 1. The mean ± SEM values obtained from the measurements and the corresponding significances are shown in Supplementary Table 1. Results were visualized using GraphPad Prism version 9.1.2. for Windows (GraphPad Software Inc, San Diego, CA, USA). Results Cellular viability Extracellular LDH activity was measured from the cell culture medium; no significant difference was observed (Fig. 1).Fig. 1Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the lactate dehydrogenase (LDH) activity of primary hepatic 3D cell co-cultures of chicken origin assessed by LDH Activity Assay Kit. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the lactate dehydrogenase (LDH) activity of primary hepatic 3D cell co-cultures of chicken origin assessed by LDH Activity Assay Kit. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. Cellular inflammation IL-6 levels were significantly increased (p=0.037) by the 100 μg/mL thymol treatment compared to the control group (Fig. 2a). In addition, in the cases of the combination treatments, a significant elevation (p=0.031; p=0.011 respectively) was observed by the effect of both thymol treatments compared to the group treated with only T-2 toxin (Fig. 2a).Fig. 2Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the level of a) interleukin-6 (IL-6), b) interleukin-10 (IL-10), c) interferon-γ (IFN-γ), d) macrophage colony-stimulating factor (M-CSF), e) “Regulated on Activation, Normal T cell Expressed and Secreted” (RANTES) of primary hepatic 3D cell co-cultures of chicken origin assessed by Luminex xMAP Technology. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. *p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.05; ##p < 0.01; ###p < 0.001. Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the level of a) interleukin-6 (IL-6), b) interleukin-10 (IL-10), c) interferon-γ (IFN-γ), d) macrophage colony-stimulating factor (M-CSF), e) “Regulated on Activation, Normal T cell Expressed and Secreted” (RANTES) of primary hepatic 3D cell co-cultures of chicken origin assessed by Luminex xMAP Technology. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. *p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.05; ##p < 0.01; ###p < 0.001. The amount of IL-10 was significantly reduced (p=0.039) by the 100 μg/mL cinnamaldehyde treatment compared to the control group (Fig. 2b). Furthermore, in combination with T-2 toxin both applied thymol concentrations significantly increased (p=0.003; p<0.001) the levels compared to the solely T-2 toxin exposed group (Fig. 2b). The IFN-γ concentration was significantly decreased (p=0.014; p<0.001, respectively) by the T-2 toxin and the 100 μg/mL cinnamaldehyde treatment (Fig. 2c). In addition, the 10 μg/mL cinnamaldehyde applied concomitantly with T-2 toxin further lowered (p=0.011) the IFN-γ concentration compared to the T-2 toxin group (Fig. 2c). In contrast, both applied combinatory thymol concentrations increased (p=0.001; p<0.001, respectively) the amount of IFN-γ relative to the T-2 toxin-treated cells (Fig. 2c). The M-CSF level was lowered (p=0.010) by 100 μg/mL thymol and elevated (p=0.022) by T-2 toxin (Fig. 2d). Furthermore, when combined with T-2 toxin, both applied concentrations of cinnamaldehyde decreased (p=0.007; p=0.022, respectively) and 100 μg/mL thymol increased (p=0.031) the M-CSF concentration compared to the T-2 toxin-treated group (Fig. 2d). Treatment with T-2 toxin, 100 μg/mL cinnamaldehyde and 100 μg/mL thymol reduced (p=0.001; p<0.001; p<0.001, respectively) the amount of RANTES (Fig. 2e). Moreover, compared to the T-2 toxin treated cells, applying 100 μg/mL cinnamaldehyde in combination with the toxin further reduced (p=0.013) the RANTES concentration (Fig. 2e). The ratio of IL-6 to IL-10 was increased (p=0.002) by 10 μg/mL cinnamaldehyde and decreased (p=0.011) by 100 μg/mL thymol compared to the T-2 toxin-treated group (Fig. 3a). The ratio of IFN-γ to IL-10 was reduced (p=0.036 and p=0.027, respectively) by both 100 μg/mL cinnamaldehyde and T-2 toxin treatments. Moreover, the 10 μg/mL cinnamaldehyde further lowered (p=0.037) the ratio compared to the toxin-treated group (Fig. 3b).Fig. 3Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the ratio of a) interleukin (IL)-6 and IL-10, b) interferon-γ (IFN-γ) and IL-10 of primary hepatic 3D cell co-cultures of chicken origin assessed by Luminex xMAP Technology. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. *p < 0.05; #p < 0.05; ##p < 0.01. Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the ratio of a) interleukin (IL)-6 and IL-10, b) interferon-γ (IFN-γ) and IL-10 of primary hepatic 3D cell co-cultures of chicken origin assessed by Luminex xMAP Technology. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. *p < 0.05; #p < 0.05; ##p < 0.01. Oxidative stress The NRF-2 level was decreased (p=0.023) by the 10 μg/mL thymol treatment (Fig. 4a). In addition, exposure to 100 μg/mL cinnamaldehyde in combination with T-2 toxin increased (p=0.025) its concentration compared to the solely T-2 toxin-treated group (Fig. 4a). In the case of MDA, both applied cinnamaldehyde concentrations lowered (p=0.023; p=0.034, respectively) its amount (Fig. 4b).Fig. 4Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the level of a) nuclear factor (erythroid-derived 2)-like 2 (NRF-2), b) malondialdehyde (MDA) of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken-specific ELISA tests. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. *p < 0.05; #p < 0.05. Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the level of a) nuclear factor (erythroid-derived 2)-like 2 (NRF-2), b) malondialdehyde (MDA) of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken-specific ELISA tests. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. *p < 0.05; #p < 0.05. Autophagy Autophagy parameters were measured from the cell lysates by chicken-specific ELISA assays. The amount of LC3B was elevated (p=0.029; p=0.048; p=0.004, respectively) by the 10 μg/mL cinnamaldehyde and both applied thymol concentrations in combination with the toxin compared to the group only treated with T-2 toxin (Fig. 5a). On the other hand, the level of P62 was decreased (p=0.031) by the toxin-combined 100 μg/mL cinnamaldehyde exposure compared to the T-2 toxin-treated group (Fig. 5b).Fig. 5Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the level of a) microtubule-associated protein 1 light chain 3 beta (LC3B), b) P62 (protein with molecular weight of 62 kDa) of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken-specific ELISA tests. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. #p < 0.05; ##p < 0.01. Effects of 24 h of T-2 toxin, cinnamaldehyde and thymol treatment on the level of a) microtubule-associated protein 1 light chain 3 beta (LC3B), b) P62 (protein with molecular weight of 62 kDa) of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken-specific ELISA tests. T-2 toxin, cinnamaldehyde and thymol-treated cells were compared to the Control group. The different groups with combination treatments were compared to the T-2 toxin group. Control: untreated cells; T-2: cells treated with 100 nM T-2 toxin; CA: cells treated with either 10 or 100 μg/mL cinnamaldehyde; THY: cells treated with either 10 or 100 μg/mL thymol. The numbers behind the abbreviations indicate the concentration of the treatment solutions. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. * indicates significant difference from the Control group, while # indicates a significant difference from the T-2 group. #p < 0.05; ##p < 0.01. Discussion In this study, the effects of T-2 toxin, a mycotoxin, and two protective substances, thymol and cinnamaldehyde, were examined in chicken-derived 3D cell cultures. These cultures better reflect in vivo conditions in comparison with classical 2D cultures; in 3D cultures, cells are more likely to keep their original phenotype and characteristics, because cells can grow in three dimensions, interact with other cells as well as the extracellular matrix (ECM) (Souza et al., 2018; van Zijl and Mikulits, 2010). For these reasons, 3D cell culture models can more accurately reflect the molecular mechanisms of different compounds than traditional cell cultures. The concentrations used in this study were determined based on preliminary in vitro studies and previous experiments conducted by our research group (Aydın et al., 2017; Lee et al., 2011; Liu et al., 2009; Shen et al., 2020b, 2020a; Vörösházi et al., 2024). In vitro experiments often involve treating cells with higher and a wider range of concentrations than those occurring or recommended in vivo. This provides a more reliable insight into the mechanisms of action of the substances studied, although validation through in vivo studies is still necessary. Measuring the activity of released cytoplasmic enzymes in the cell culture media is a common method for determining cytotoxicity (Kumar et al., 2018). One such enzyme is LDH, which is released into the media of cells in case of cell membrane damage (Vörösházi et al., 2024). There was no significant difference measured in LDH activity, suggesting that the treatments did not significantly damage cells and that the applied 100 nM concentration of T-2 toxin was not cytotoxic. This aligns with preliminary results obtained by our research group that 100 nM T-2 toxin concentration is considered as a sublethal dose for 3D cultured hepatic cells (Vörösházi et al., 2024). During this investigation, changes in the concentration of several inflammatory parameters were also monitored. Cytokines are important regulators of the immune response, as they play a role in cell-cell communication, as well as in cell activation, maturation, and differentiation (Xue et al., 2010). In the present study, the amount of IL-6 was increased by the 100 µg/mL thymol when applied alone. Although thymol generally has an anti-inflammatory activity, there may be cases that can influence this effect. Studies conducted on murine macrophage cells showed that thymol can stimulate macrophage respiratory burst in a concentration-dependent manner, which is accompanied by superoxide generation (Chauhan et al., 2014). During phagocytosis, the phagocyte NADPH oxidase enzyme (respiratory burst oxidase) produces superoxide anion, which is a key event in the antigen response. This phagosomal and membrane-associated enzyme complex is normally dormant but is quickly activated when cells are stimulated (Chauhan et al., 2014; Nauseef, 2004). Moreover, the superoxide anion produced can then serve as a precursor for several oxidant substances (Dinauer, 2005). Thus, it can be hypothesized that thymol at certain concentrations can induce mild oxidative stress in cells, which is associated with the activation of the nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, which upregulate IL-6 production (Son et al., 2008). When thymol was applied in combination with T-2 toxin, IL-6 levels also increased compared to the only T-2 toxin-treated cells. However, in this experiment, T-2 toxin alone did not increase IL-6 levels. It has long been known that trichothecenes can significantly increase cytokine mRNA expression; however, due to the inhibition of translation, this does not necessarily result in a change in protein levels (Azcona-Olivera et al., 1995; Ouyang et al., 1995). Since in this experiment changes in IL-6 were monitored only at the protein level, an increase at the mRNA level cannot be ruled out. This is supported by the fact that an increase in the amount of IL-6 was observed when used in combination with thymol. In cells already exposed to stress, thymol may exert a negative effect by temporarily enhancing ROS signaling as mentioned above, which may lead to further NF-κB activation (Chauhan et al., 2014). It is possible that the T-2 toxin “primed” IL-6 production, and then thymol further amplified this effect, triggering the increase that was measurable at the protein level. Furthermore, IL-6 is not only a component of inflammation but also plays a key role in liver regeneration and repair (Wang et al., 2024). Therefore, it is possible that thymol increased its levels to restore the homeostasis of hepatic cells. Furthermore, although thymol increased IL-6 levels in combination with T-2 toxin, it elicited a more pronounced increase in IL-10 levels. IL-10 is primarily an anti-inflammatory cytokine whose main role is to reduce the inflammatory response, thereby protecting tissues from damage (Iyer and Cheng, 2012; Nagata and Nishiyama, 2021). The decrease in the IL-6/IL-10 ratio suggests that the overall immune response shifted towards an anti-inflammatory profile, likely due to a more pronounced induction of IL-10. It therefore appears that thymol acts as a pro-oxidative trigger, but at the same time induces anti-inflammatory responses. In contrast, the IL-6/IL-10 ratio increased following combination treatment with T-2 toxin and cinnamaldehyde, which may indicate inflammation within the cells. The increase in the IL-6/IL-10 ratio following co-treatment with T-2 toxin and cinnamaldehyde may be explained by a disproportionate suppression of IL-10 relative to IL-6. Although cinnamaldehyde did not elevate cytokine levels overall; it may have preferentially reduced anti-inflammatory signaling, thereby shifting the cytokine balance towards a pro-inflammatory state. Cinnamaldehyde is usually described as an anti-inflammatory compound, although it demonstrated dose-dependent effects, including the mild activation of NF-κB signaling at low concentrations and induction of inflammatory responses (Roth-Walter et al., 2014). This subtle activation may explain the observed increase in the IL-6/IL-10 ratio under the combination treatments. Of the inflammatory parameters measured, IL-10, IFN-γ, and RANTES are reduced by 100 μg/mL cinnamaldehyde, the latter also being lowered by thymol. The reduction in the IL-10 levels is consistent with prior literature data, which reported that cinnamaldehyde, either alone or in combination with vitamin C, reduced the mRNA expression of certain interleukins, including IL-10, in the intestines of broiler chickens (Huang et al., 2024). This cytokine-decreasing effect may be mediated through the inhibition the NF-κB pathway (Chao et al., 2008; Roth-Walter et al., 2014; Youn et al., 2008). T-2 toxin and both concentrations of thymol together elevated the amount of IL-10, showing a similar trend to the change in the IL-6 levels. The positive correlation between IL-6 and IL-10 levels is probably due to the promotion of IL-10 production by IL-6 (Fu et al., 2017; Jin et al., 2013). IL-6 is a pleiotropic cytokine with diverse roles: it participates in inflammation, immune regulation, and tissue repair (Tanaka et al., 2014). An in vitro study conducted by Jin et al. showed that IL-6 was able to catalyze the transformation of naive CD4+ T cells into IL-10-producing Tr1 cells (Jin et al., 2013). Studies conducted on tumor tissues also observed that IL-6 induced the differentiation of normal macrophages into M2 macrophages with higher IL-10 and transforming growth factor β (TGF-β) expression as well as lower IL-12 expression through the activation of signal transducer and activator of transcription (STAT) 3 phosphorylation (Fu et al., 2017). There are two possible directions of this activation: M1 or classical, and M2 or alternative activation. M1 macrophages are characterized by pro-inflammatory activity, while M2 macrophages are characterized by anti-inflammatory activity and play a role in restoring tissue homeostasis (Jeannin et al., 2018; Rőszer, 2015). M2 activation is induced by fungal cells, parasites, immune complexes, apoptotic cells, M-CSF, and various cytokines (Rőszer, 2015). The level of IFN-γ was reduced by the T-2 toxin treatment. The effect of T-2 toxin on immune cell function can be concentration-, exposure duration-, and cell type-dependent. Higher concentrations increase, while lower concentrations decrease cytokine production (Ahmadi and Riazipour, 2008). Our results align with the hypothesis that under certain circumstances, the toxin can suppress cellular immunity. This is in agreement with an in vitro study by Ahmadi and Riazipour in which T-2 toxin concentrations between 1 and 100 nM decreased the amount of IL-2 and IFN-γ in mouse lymph node T cells (Ahmadi and Riazipour, 2008). In addition, it has been described that T-2 toxin reduced the amount of IFN-γ in the digestive tract during the response to reovirus infection, thereby increasing the time of infection in mice (Li et al., 2006). In chickens, it has also been observed in vivo that in combination with ochratoxin A, T-2 toxin reduced both the expression and concentration of IL-2 and IFN-γ (Xue et al., 2010). In addition, the IFN-γ/IL-10 ratio also decreased following treatment with T-2 toxin, which further supports the mitigation of cellular immunity. The amount of IFN-γ was also lowered by the 100 µg/m cinnamaldehyde treatment. As mentioned above, cinnamaldehyde is capable of inhibiting NF-κB activation (Chao et al., 2008; Roth-Walter et al., 2014; Youn et al., 2008). This inhibition may also cause a decrease in IFN-γ concentration (Pfeffer, 2011; Sica et al., 1997). Cinnamaldehyde in combination with T-2 toxin further reduced IFN-γ levels compared to the group treated with mycotoxin alone. The cytokine-decreasing effect of cinnamaldehyde, combined with the IFN-γ-reducing effect of T-2 toxin, may result in this outcome. These hypotheses are consistent with the results obtained from the analysis of cytokine ratios, which showed that the IFN-γ/IL-10 ratio decreased in response to higher levels of cinnamaldehyde and during combination treatment in a similar manner. Interestingly, IFN-γ levels increased in response to combination treatment with T-2 toxin and thymol. IFN-γ is a macrophage-activating cytokine that triggers antimicrobial and antigen-presenting functions and plays a key role in host defense against intracellular pathogens (Schroder et al., 2004). As discussed earlier, both the translational inhibitory effects of T-2 toxin and the context-dependent pro-oxidant activity of thymol may contribute to the observed interaction (Chauhan et al., 2014). While T-2 toxin alone may prime cytokine expression at the mRNA level without increasing protein levels – and may even suppress cytokines such as IFN-γ – thymol can induce mild oxidative stress through ROS generation, activating NF-κB and MAPK pathways. In this primed cellular state, thymol may act as an amplifying factor, resulting in a detectable increase in the cytokine production. This may explain why thymol exerted a pronounced enhancing effect only in combination with T-2 toxin, but not when applied alone. IFN-γ is often able to increase the production of inflammatory cytokines, including tumor necrosis factor (TNF), IL-6, and p40, in response to inflammatory factors via the NF-κB pathway (Qiao et al., 2013). Accordingly, in lipopolysaccharide (LPS)-treated human macrophage cells, IFN-γ stimulated the production of TNF, IL-6, and IL-12 (Qiao et al., 2013). In human neutrophils, it also induced IL-6 expression via the Janus kinase (JAK) 1/2-STAT1 pathway (Yoshida et al., 2021). Therefore, it is hypothesized that in the present study, the elevated IFN-γ production stimulated IL-6 release in cells, which was accompanied by an increase in IL-10 concentration, reflected by the similar pattern of the IFN- γ, IL-6 and IL-10 concentrations of the toxin and thymol combination exposed groups. Among the inflammatory parameters, T-2 toxin treatment elevated the amount of M-CSF. M-CSF is a key cytokine that plays an important role in the maintenance and survival of mononuclear phagocyte cells including macrophages, as well as in the differentiation of their progenitors (Chen et al., 2021; Yi et al., 2024). T-2 toxin–induced hepatocellular damage may activate Kupffer cells, leading to elevated M-CSF release. M-CSF, in turn, drives macrophage polarization towards the reparative M2 phenotype, contributing to the restoration of cellular homeostasis. Cinnamaldehyde was able to alleviate the increase in M-CSF level compared to cells treated with T-2 toxin alone. This was probably also achieved through the aforementioned inhibition of NF-κB activation (Kim et al., 2010). Thymol alone reduced the amount of M-CSF compared to untreated cells. The decrease in the M-CSF concentration aligns with previous data on the effects of thymol, as it is a well-documented anti-inflammatory and antioxidant agent that inhibits the NF-κB pathway and stimulates the antioxidant response via the NRF-2/HO-1 pathway (Gago et al., 2025). On the other hand, the amount of M-CSF increased as a result of the combination treatment with thymol. As M-CSF stimulates the activation of M2 macrophages, it is likely that M-CSF and IL-6 synergistically increased M2 macrophage activation, resulting in a measurable elevation in IL-10 levels, which in turn may have influenced the change in M-CSF levels (Y.-C. Chen et al., 2021; Jeannin et al., 2018). Overall, elevated IL-10 and M-CSF often represent an anti-inflammatory, reparative macrophage phenotype: this may be a compensation mechanism for the pro-inflammatory state induced by the T-2 toxin, during which cells attempt to restore their homeostasis facilitated by thymol. Besides IFN-γ, the amount of RANTES also declined in response to T-2 toxin. RANTES (or C-C chemokine ligand 5 – CCL-5) is a C-C chemokine, being an NF-κB target gene expressed by several cell types, including macrophages (Aldinucci and Colombatti, 2014; Soria and Ben-Baruch, 2008). Activation of NF-κB induces RANTES production (Chenoweth et al., 2012). Since T-2 toxin can cause immunosuppression at certain doses, it could have reduced the amount of RANTES (Ahmadi and Riazipour, 2008; Zhang et al., 2022). In addition, according to preliminary literature data, there is a correlation between RANTES and IFN-γ levels, as IFN-γ is capable of stimulating RANTES production in several cell types (Kawka et al., 2014; Liu et al., 2005). Therefore, a decline in IFN-γ levels may also lead to a decrease in RANTES. Interferon regulatory factor 1 (IRF-1) is an important transcription factor in IFN-γ-mediated signaling (Liu et al., 2005). Liu et al. demonstrated that in IRF-1-null mice, RANTES levels were reduced, particularly in macrophages (Liu et al., 2005). Moreover, RANTES expression was also studied in vivo in mouse models of transplant rejection, where it was also observed that IRF-1 controls RANTES expression and the RANTES-mediated immune response (Erickson et al., 2004). Cinnamaldehyde alone reduced RANTES levels in correlation with IL-10 and IFN-γ. This reduction is also likely due to the aforementioned inhibition of NF-κB activation (Chao et al., 2008; Roth-Walter et al., 2014; Youn et al., 2008). In addition to regulating the production of inflammatory mediators, NF-κB is also associated with IRF signaling pathways. NF-κB factors probably have a direct effect on the IRF family, so inhibition of NF-κB may also suppress the IRF pathway, causing a decrease in the RANTES concentration (Iwanaszko and Kimmel, 2015). Moreover, the amount of IFN-γ was also reduced in this group, which may have caused a further decrease in RANTES in the manner described above (Kawka et al., 2014; Liu et al., 2005). Cinnamaldehyde, together with T-2 toxin further reduced the amount of RANTES. This is likely due to the immunosuppressive effect of T-2 toxin and the NF-κB inhibitory effect of cinnamaldehyde (Ahmadi and Riazipour, 2008; Chao et al., 2008; Roth-Walter et al., 2014; Youn et al., 2008). Simultaneously with this decrease, the amount of IFN-γ also declined, which may also have resulted in the decrease in RANTES (Kawka et al., 2014; Liu et al., 2005). The amount of RANTES was also reduced by thymol. This is consistent with what is already known about thymol, namely that it is an anti-inflammatory and antioxidant substance, than can have a suppressive effect on the cytokine production (Gago et al., 2025; Nagoor Meeran et al., 2017). To monitor oxidative stress, we followed changes in two parameters: NRF-2 and malondialdehyde (MDA) levels. NRF-2 levels decreased in response to thymol treatment. NRF-2 is a transcription factor that plays a role in the regulation of antioxidant, anti-inflammatory, and cytoprotective genes (Gao et al., 2022; Xu et al., 2018). Normally, it is found in the cytoplasm, but under oxidative stress, it translocates to the nucleus, where it binds to antioxidant response elements (ARE) and regulates them (Gao et al., 2022; Kensler et al., 2007; Nguyen et al., 2009). One of the antioxidant properties of thymol is its direct free radical scavenging ability, which reduces intracellular reactive oxygen species (ROS) levels (Gholami-Ahangaran et al., 2022). In this case, cells probably need less NRF-2, which could lead to the reduction in the amount of NRF-2. Interestingly, cinnamaldehyde, together with T-2 toxin, increased NRF-2 levels compared to cells treated with mycotoxin alone. In some cases, T-2 toxin can reduce NRF-2 levels. For example, in MCF-7 cells, it promoted ROS accumulation and downregulated NRF-2 gene expression (Chen et al., 2021). Cinnamaldehyde, on the other hand, can often elevate the amount of NRF-2; it enhances NRF-2 nuclear translocation in HepG2 cells and activates the NRF-2 signaling in keratinocytes (Huang et al., 2011; Uchi et al., 2017). In this study, a numerical – but not statistically significant – decreasing effect of T-2 toxin was detected. It is hypothesized that when used in combination, cinnamaldehyde restored or even increased NRF-2 activation suppressed by T-2 toxin, resulting in the observed elevation in NRF-2 levels. The amount of MDA decreased after cinnamaldehyde treatment. MDA is a lipid peroxidation marker, the amount of which increases as a result of lipid peroxidation caused by oxidative stress (Tsikas, 2017). As mentioned above, cinnamaldehyde promotes the translocation of NRF-2 to the nucleus, which then activates AREs (Gao et al., 2022; Huang et al., 2011; Kensler et al., 2007; Nguyen et al., 2009). This antioxidant cascade is then able to detoxify ROS, thereby preventing lipid peroxidation. In this study, two markers of autophagy, LC3B and P62 were monitored to investigate the changes in the cell death processes. When used in combination with T-2 toxin, cinnamaldehyde increased the amount of LC3B and decreased the amount of P62. LC3B is an autophagosome membrane marker whose cytosolic form (LC3-I) is lipidated during autophagy and converted to LC3-II, which plays a role in the formation of autophagosome membranes (Tanida et al., 2008). P62 is a selective autophagy receptor and polyubiquitin-binding protein that is degraded during autophagy. It plays a key role in the degradation of polyubiquitinated protein aggregates, acting in cooperation with LC3B (Kumar et al., 2022; Pankiv et al., 2007). During active autophagy, P62 binds to substrates for breakdown and is then enclosed in autophagosomes via binding to LC3, where it is degraded (Bjørkøy et al., 2005). Cinnamaldehyde can induce autophagy in cells by promoting the expression of Beclin-1, ATG5, and LC3B and inhibiting the expression of P62 (Kim, 2022). This, acting synergistically with the stress potentially induced by T-2 toxin, was able to increase LC3B, while decrease P62 levels. Combination treatment with thymol and T-2 toxin also elevated LC3B levels. Like cinnamaldehyde, thymol can modulate autophagy and increase LC3B levels (Guo et al., 2023). This effect, combined with the stress-inducing effect of T-2 toxin, may have resulted in this elevation. These results suggest that both cinnamaldehyde and thymol enhanced autophagic activity in T-2 toxin-exposed cells, as indicated by increased LC3B levels and, in the case of cinnamaldehyde, decreased P62 levels. This effect is likely due to the combined action of these compounds and toxin-induced cellular stress, leading to activation of autophagy-related pathways. Conclusion In this study, the effects of T-2 toxin and two protective plant-derived compounds were examined on chicken-derived hepatic cell cultures. Our results show that the applied substances did not affect cellular viability; the concentration of T-2 toxin used was not cytotoxic, and the protective agents did not affect viability either. However, complex immunomodulatory effects of the toxin were observed. In general, T-2 toxin was able to alter the levels of pro- and anti-inflammatory cytokines in both directions, while thymol had a general increasing activity, and cinnamaldehyde had a decreasing effect on most inflammatory parameters. Based on the results of the cytokine ratios, both substances exhibited mostly an anti-inflammatory effect; however, their effects on cytokines are multifaceted and depend largely on the cell type, the duration of exposure, and the dose of the treatment solution. Overall, these results indicate that the interactions between individual cytokines are complex, coordinately regulated, and suggest a broader spectrum of macrophage responses. Based on the oxidative parameters investigated, T-2 toxin alone did not induce measurable oxidative stress in the cells, but thymol and cinnamaldehyde exerted an antioxidant effect. Moreover, autophagy was initiated in the cells as a result of the combination treatments. Based on these findings, it can be concluded that T-2 toxin exerted its negative effects by influencing inflammatory processes, but this was not cytotoxic, and the cells were able to counteract it by activating the autophagy mechanism. Moreover, the protective agents investigated in this study may represent promising candidates for feed additive applications; however, the present findings should be interpreted with consideration of the limitations of in vitro models, which cannot fully reflect the complex physiological conditions and interactions occurring in vivo. Therefore, further studies are required to elucidate the underlying signaling pathways, associated mRNA expression changes, and to validate the present results in vivo, particularly regarding the efficacy, safety, and practical applicability of these compounds as potential feed additives. Author contributions All authors contributed substantially to the conception and design of the study. Júlia Vörösházi contributed to the methodology, experimental work, data collection and investigation, data visualization, and preparation of the original manuscript. Máté Mackei, Rege Anna Márton, Evelin Kámán-Tóth and Ágnes Kemény contributed to the experimental work and data collection. Zsuzsanna Neogrády and Gábor Mátis contributed to the experimental work, the supervision of the study, while Gábor Mátis was also responsible for funding acquisition. All authors critically reviewed the manuscript for important intellectual content, approved the final version of the manuscript, and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved. Disclosures The authors declare that there are no conflicts of interest related to this work.